Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Hua Gong

Hua Gong

individual
Ecosystem influencer

About

Hua Gong, MD, PhD is a biopharma executive focused on translational medicine, biomarkers, precision medicine, and oncology drug development. She joined BridgeBio Oncology Therapeutics in December 2024 as Vice President, Translational Medicine after serving as Senior Vice President of Translational Medicine at Zai Lab and earlier as Chief Operating Officer and Head of Precision Medicine at Adagene. Her background spans diagnostics, biomarker strategy, and clinical/preclinical development across multiple oncology programs.

Areas of interest

oncologytranslational medicineprecision medicinebiomarkersdrug developmentdiagnosticsbiopharma